SYS1, also known as "SYS1 Golgi trafficking protein," is a relatively uncharacterized human protein encoded by the SYS1 gene. While detailed functional insights are limited, SYS1 is believed to be involved in intracellular trafficking, particularly associated with the Golgi apparatus, which is a key organelle in the processing and sorting of proteins and lipids in the cell.Based on its name and the limited available data, SYS1 may play a role in the maintenance of Golgi structure or in the regulation of vesicular transport between the Golgi and other cellular compartments. The Golgi apparatus is critical for the proper functioning of eukaryotic cells, as it is central to the secretory pathway, modifying proteins and lipids received from the endoplasmic reticulum and directing them to their final destinations.
The protein's precise mechanisms of action, its interaction partners within the Golgi trafficking machinery, and its implications for cell physiology are subjects that would benefit from further research. It is possible that SYS1 partners with other proteins that are better characterized in the context of Golgi function, and dissecting these interactions could provide a clearer picture of its role.SYS1 may also be implicated in various cellular processes that rely on effective Golgi function, such as protein glycosylation, membrane trafficking, and cell signaling. Dysregulation of such processes may have implications for various diseases, including those related to protein misfolding and trafficking disorders.
Items 1 to 10 of 12 total
Mostrar:
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
La brefeldina A altera la estructura y función del Golgi, afectando potencialmente a los procesos de tráfico relacionados con SYS1. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
La monensina es un ionóforo que altera la función del Golgi, lo que podría influir indirectamente en la actividad de SYS1. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
El nocodazol altera la dinámica de los microtúbulos, afectando al transporte de vesículas y repercutiendo potencialmente en la función de SYS1. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
El golgicida A se dirige específicamente al aparato de Golgi, influyendo potencialmente en los procesos relacionados con SYS1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
La forskolina modula los niveles de AMPc, lo que puede influir en diversos procesos celulares, incluidos potencialmente los que implican a SYS1. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
La tunicamicina inhibe la glicosilación ligada a N en el RE, lo que afecta al tráfico de proteínas y, potencialmente, a la actividad de SYS1. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
La cloroquina, al alterar el pH endosomal y lisosomal, puede afectar a las vías de tráfico de proteínas, impactando potencialmente en SYS1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
La wortmannina es un inhibidor de la PI3 cinasa que afecta al tráfico de vesículas y posiblemente a la función de SYS1. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibe la dinamina, afectando a la endocitosis y al tráfico vesicular, lo que podría influir en SYS1. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
El ácido retinoico influye en la diferenciación celular y puede afectar indirectamente a SYS1 a través de cambios en la organización celular. | ||||||